ESSA PHARMA INCEquity-NMS: EPIX
Equity-NMS: EPIX
$2.91
-0.02
(3 Aug)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$2.91
Open
$2.91
1Y
-1.69%
5Y
-6.15%
Market cap
0
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About ESSA PHARMA INC

ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

.


FAQs

Can I buy ESSA PHARMA INC shares in India?
How to buy ESSA PHARMA INC shares in India?
What is the share price of ESSA PHARMA INC?
What is the Market Capitalization of ESSA PHARMA INC?
What is the PE ratio of ESSA PHARMA INC?
Is ESSA PHARMA INC a good stock to buy?
In which sector / industry does ESSA PHARMA INC operate?